Itching To Succeed: UNION Buys LEO Pharma’s PDE4 Inhibitor Series

Danish Biotech Says PDE4 Inhibitor Series ‘Brings Pipeline Synergies’

 
• By Sten Stovall

Denmark-based UNION therapeutics has bought LEO Pharma’s PDE4 inhibitor compound series for use in developing treatments for psoriasis and atopic dermatitis.

Skin
UNION’s focus is immuno-dermatology, including psoriasis and atopic dermatitis. • Source: Shutterstock

More from Deals

More from Business